Effectiveness and Safety of Meropenem/Clavulanate-Containing Regimens in the Treatment of MDR- And XDR-TB

European Respiratory Journal - United Kingdom
doi 10.1183/13993003.02146-2015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

European Respiratory Society (ERS)

Related search

Efficacy, Safety and Tolerability of Linezolid Containing Regimens in Treating MDR-TB and XDR-TB: Systematic Review and Meta-Analysis

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2012English

Ireland’s Potential MDR-TB and XDR-TB Problem

Irish Journal of Medical Science
Medicine
2010English

Methodological Considerations in Clinical Trials for New MDR-TB Treatment Regimens

International Journal of Tuberculosis and Lung Disease
MedicinePulmonaryInfectious DiseasesRespiratory Medicine
2016English

Efficacy, Safety and Tolerability of Linezolid for the Treatment of XDR-TB: A Study in China

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2014English

Predictive Factors for Unfavourable Treatment in MDR-TB and XDR-TB Patients in Rio De Janeiro State, Brazil, 2000-2016

PLoS ONE
Multidisciplinary
2019English

Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2013English

The Changing Treatment Landscape for MDR/XDR-TB — Can Current Clinical Trials Revolutionise and Inform a Brave New World?

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Pyrido[1,2-A]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2011English

Relationship Between TB Treatment Phase and Knowledge of MDR TB With TB Patient’s Compliance

Jurnal Berkala Epidemiologi
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy